FEATURE ARTICLES

Growing a Compounding Practice: Successful Marketing to Underserved Populations

Expecting the Expected: Planning Considerations for Cleanroom Construction

Compounding Pearls - Wound Care: Drugs and Formulations for Dermal Healing, Part 2

Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists

A Permanent Path for Urgent-Use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot

APPLIED COMPOUNDING

How to Produce a Well-Closed Sealed Vial in a Regulated CGMP Environment: Part 1

Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases

Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues

PEER REVIEW

Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions

Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base

Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases

DEPARTMENTS

Prescription: Endemics, Epidemics, and Pandemics

Calculations

Index of Advertisers

FORMULATIONS

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube

Atomoxetine 4-mg/mL Oral Solution/Suspension

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)

Budesonide 0.025% Mucoadhesive Gel

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5% and Tropicamide 0.5% Ophthalmic Solution

Hydrocortisone 2-mg/mL in Oral Mix Suspension

MOH's Paste, Modified

Nifedipine 4 mg/mL in SyrSpend SF PH4 Cherry Flavored

Tacrolimus 0.1% Topical Microemulsion

Valsartan 4 mg/mL in SyrSpend SF PH4